ArticlePublic health reports (Washington, D.C. : 1974)2026
Factors Affecting Maternal Respiratory Syncytial Virus Vaccination and the Impact on Infant Hospitalization During the 2023-2024 Season in Dallas, Texas.
Article in Public health reports (Washington, D.C. : 1974), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
objectivesThis study assessed factors associated with respiratory syncytial virus (RSV) immunization rates among pregnant women and evaluated the effectiveness of maternal RSV vaccination on infant hospitalization rates.
methodsWe collected data on mothers and their newborns born at a university-affiliated hospital in Dallas, Texas, during the 2023-2024 RSV season if they responded to a telephone survey and confirmed their vaccination status. We used logistic regression to assess associations between demographic factors and receipt of maternal RSV vaccination. We confirmed infant RSV hospitalization by telephone survey and calculated maternal RSV vaccination effectiveness against RSV-associated hospitalization.
resultsFrom November 1, 2023, through February 29, 2024, 179 of 656 women (27%) received the maternal RSV vaccine. Women aged <30 years were less likely to be vaccinated than older women (
conclusionsDemographic disparities existed among women who received maternal RSV vaccination, and RSV vaccination lowered infant RSV hospitalization rates.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.